AdvanDx Lands $8,000,000 Series C Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=50ba92b4-15d1-4704-901f-20d8b4d674a0&Preview=1 -
Date
8/18/2009 -
Company Name
AdvanDx -
Mailing Address
10A Roessler Road Woburn, MA 01801 -
Company Description
AdvanDx develops and markets molecular-based, in vitro diagnostic tests that aid in the diagnosis and prevention of infectious diseases. The rapid test results are available in hours instead of days and allow healthcare providers to make more informed therapy decisions early and improve both the quality of patient care and overall hospital operations. -
Website
http://www.advandx.com -
Transaction Type
Venture Equity -
Transaction Amount
$8,000,000 -
Transaction Round
Series C -
Proceeds Purposes
The funding will be used to fund the expansion of AdvanDx’s molecular diagnostics product offering as well as its international sales and marketing activities. -
M&A Terms
-
Venture Investor
SLS Ventures -
Venture Investor
Undisclosed
